Skip to content
10-K

Annual Report

VYCOR MEDICAL, INC. VYCO

0001641172-25-004744

← back to feed
Filed
Apr 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 15, 2025 33.37M sh
Shares Diluted FY 2024 · Dec 31, 2023 32.6M sh
Capex FY 2024 · Dec 31, 2023 $9.39K
Operating Cash Flow FY 2024 · Dec 31, 2023 $29.43K
Cash And Equivalents FY 2024 · Dec 31, 2023 $57.29K
Current Liabilities FY 2024 · Dec 31, 2023 $4.07M
Total Liabilities FY 2024 · Dec 31, 2023 $4.32M
Current Assets FY 2024 · Dec 31, 2023 $584.09K
Total Assets FY 2024 · Dec 31, 2023 $992.3K
Eps Diluted FY 2024 · Dec 31, 2023 −$0.01
Eps Basic FY 2024 · Dec 31, 2023 −$0.01
Sga Expense FY 2024 · Dec 31, 2023 $1.2M
Rd Expense FY 2024 · Dec 31, 2023 $22.56K
Net Income FY 2024 · Dec 31, 2023 −$69.69K
Operating Income FY 2024 · Dec 31, 2023 $40.19K
Gross Profit FY 2024 · Dec 31, 2023 $1.32M
Cost Of Revenue FY 2024 · Dec 31, 2023 $144.95K
Revenue FY 2024 · Dec 31, 2023 $1.46M
Stockholders Equity FY 2024 · Dec 31, 2022 −$2.94M